Evidence map›Paper›PMID 36532440›Full record

ArticleFrontiers in microbiology2022

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells.

Zhenlong Liu, Émilie Larocque, Yongli Xie, Yong Xiao, Guy Lemay, Jean-Marie Peloponese, Jean-Michel Mesnard, Éric Rassart, Rongtuan Lin, Shuang Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Zhenlong LiuDépartement de chimie, Université du Québec à Montréal, Montréal, QC, Canada.
Émilie LarocqueCentre d'excellence en recherche sur les maladies orphelines-Fondation Courtois, Université du Québec à Montréal, Montréal, QC, Canada.
Yongli XieInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China.
Yong XiaoDépartement de chimie, Université du Québec à Montréal, Montréal, QC, Canada.
Guy LemayDépartement de microbiologie et immunologie, Université de Montréal, Montréal, QC, Canada.
Jean-Marie PeloponeseInstitut de Recherche en Infectiologie de Montpellier (IRIM), CNRS, Université Montpellier, Montpellier, France.
Jean-Michel MesnardInstitut de Recherche en Infectiologie de Montpellier (IRIM), CNRS, Université Montpellier, Montpellier, France.
Éric RassartCentre d'excellence en recherche sur les maladies orphelines-Fondation Courtois, Université du Québec à Montréal, Montréal, QC, Canada.
Rongtuan LinLady Davis Institute, Jewish General Hospital & Department of Medicine, McGill University, Montreal, QC, Canada.
Shuang ZhouNeurosurgery Department, 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Yiming ZengNeurosurgery Department, 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Hongzhi GaoNeurosurgery Department, 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Shan CenInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China.
Benoit BarbeauDépartement de chimie, Université du Québec à Montréal, Montréal, QC, Canada.
Université du Québec à Montréal · CAChinese Academy of Medical Sciences & Peking Union Medical College · CNMcGill University · CASecond Affiliated Hospital of Fujian Medical University · CNUniversité de Montpellier · FRUniversité de Montréal · CAFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-cell leukemia virus type 1 is the causative agent of HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia-lymphoma (ATL). The HTLV-1 basic leucine zipper factor (HBZ) has been associated to the cancer-inducing properties of this virus, although the exact mechanism is unknown. In this study, we identified nucleophosmin (NPM1/B23) as a new interaction partner of HBZ. We show that sHBZ and the less abundant uHBZ isoform interact with nucleolar NPM1/B23 in infected cells and HTLV-1 positive patient cells, unlike equivalent antisense proteins of related non-leukemogenic HTLV-2, -3 and-4 viruses. We further demonstrate that sHBZ association to NPM1/B23 is sensitive to RNase. Interestingly, sHBZ was shown to interact with its own RNA. Through siRNA and overexpression experiments, we further provide evidence that NPM1/B23 acts negatively on viral gene expression with potential impact on cell transformation. Our results hence provide a new insight over HBZ-binding partners in relation to cellular localization and potential function on cell proliferation and should lead to a better understanding of the link between HBZ and ATL development.

Indexed as

APH-2ATLLcell transformationHBZHTLV-1NPM1/B23nucleolusRNA binding

Identifiers

PMID36532440
PMCPMC9753777
OpenAlexW4311069459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.